Biotech News
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
ir.cvrx.com2026-05-06 15:02 EST
MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and